Looking to publish in Therapeutic Advances in Endocrinology and Metabolism? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginTherapeutic Advances in Endocrinology and Metabolism is a peer-reviewed open access journal focused on pioneering efforts and innovative studies across all areas of endocrinology and metabolism.
Looking to publish in Therapeutic Advances in Endocrinology and Metabolism? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Therapeutic Advances in Endocrinology and Metabolism accepts the following article types. Click on an article type to view submission instructions.
Original Articles
Review Articles
Scoping Reviews
Systematic Reviews
Meta-Analyses
Case Reports
Case Series
Brief Reports
Letters To The Editor
Recent Publications
Association between HOMA-IR and coexisting MASLD and type 2 diabetes: Insights from NHANES and network pharmacology
Xian-Pei Heng, Liu-Qing Yang, Qi-Wei Chen, Lin-Xi Jin, Yu-Wan Li, Yi Ruan, Zhuang Han, Shu-Hong Yao, Xin-Miao Hong, Zhi-Ta Wang, Liang Li, Wei-Dong He
Association between glycerol triglyceride glucose-related index and cardiovascular disease in individuals with metabolic dysfunction-associated steatotic liver disease: NHANES 1999–2023
Songshan Li, Shuling Rong, Bin Yang, Huili Cao, Huwei Dai, Yajing Zhao, Bao Li
A phase 3, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of vosoritide in children with hypochondroplasia: CANOPY HCH-3 study design
Andrew Dauber, Ravi Savarirayan, Ricki Carroll, Moira Cheung, Valérie Cormier-Daire, Mohamad Maghnie, Noriyuki Namba, Oliver Semler, Sajda Ghani, Ian Sabir, Roberto Bassi
GLP-1 receptor agonists at the crossroads of metabolic and gut inflammation: Implications for people with type 2 diabetes and inflammatory bowel disease
Dured Dardari
Teplizumab in stage 2 type 1 diabetes- pediatric considerations, realistic expectations, and the evolving technological landscape
Hussein Zaitoon
Frequently asked questions
How long does it take to publish?
Manuscripts are reviewed by at least two referees. Online First publication is usually within 3 weeks of acceptance.
Reformat to Therapeutic Advances in Endocrinology and Metabolism using Livewrite PremiumIs a cover letter required?
A cover letter is required and should indicate why the manuscript is suitable for publication. Writing or editing assistance and third-party submission arrangements must also be stated in the covering letter when applicable.
Reformat to Therapeutic Advances in Endocrinology and Metabolism using Livewrite PremiumWhat are the publication costs?
The journal is open access. The standard APC is $3,000 USD, payable on acceptance after peer review and before publication. Editorials and Letters to the Editor are free of charge. Plain Language Summary of Publications (PLS-Ps) carry an APC of $5000.
Reformat to Therapeutic Advances in Endocrinology and Metabolism using Livewrite Premium